HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vidhya A Nair Selected Research
Vidhya A Nair Research Topics
Disease
5
Neoplasms (Cancer)
01/2024 - 05/2017
3
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 11/2019
3
Colonic Neoplasms (Colon Cancer)
10/2022 - 05/2017
3
Breast Neoplasms (Breast Cancer)
05/2020 - 05/2017
2
Neoplasm Metastasis (Metastasis)
09/2022 - 09/2017
1
Obesity
01/2024
1
Glioma (Gliomas)
09/2022
1
Muscular Atrophy (Muscle Atrophy)
07/2022
1
Inflammation (Inflammations)
01/2021
1
Lymphatic Metastasis
11/2019
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2019
1
Carcinogenesis
09/2017
Drug/Important Bio-Agent (IBA)
3
Fluorouracil (Carac)
FDA Link
Generic
01/2023 - 05/2017
2
Calmodulin-Binding Proteins (Caldesmon)
IBA
01/2023 - 09/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 09/2022
2
Protein Isoforms (Isoforms)
IBA
01/2023 - 09/2022
2
bisphenol A
IBA
10/2022 - 05/2020
1
Cytokines
IBA
01/2024
1
Adipokines
IBA
01/2024
1
Antibodies
IBA
01/2023
1
Microfilament Proteins (Actin Binding Proteins)
IBA
09/2022
1
4-phenylbutylamine
IBA
07/2022
1
hexabromocyclododecane
IBA
05/2020
1
octylphenol
IBA
05/2020
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
11/2019
1
Checkpoint Kinase 2
IBA
11/2019
1
Calponins
IBA
11/2019
1
Formaldehyde (Formol)
FDA Link
11/2019
1
Paraffin
IBA
11/2019
1
Phosphotransferases (Kinase)
IBA
11/2019
1
Chaperonin 60
IBA
11/2019
1
Catenins
IBA
11/2019
1
moesin
IBA
09/2017
1
MicroRNAs (MicroRNA)
IBA
09/2017
1
Irinotecan (Camptosar)
FDA Link
Generic
05/2017
1
Axl Receptor Tyrosine Kinase
IBA
05/2017
1
Proteins (Proteins, Gene)
FDA Link
05/2017
1
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2017
1
lissamine rhodamine B (sulforhodamine B)
IBA
05/2017
Therapy/Procedure
4
Therapeutics
01/2023 - 05/2017
2
Drug Therapy (Chemotherapy)
01/2024 - 11/2019
1
Combination Drug Therapy (Combination Chemotherapy)
01/2023
1
Chemoradiotherapy
09/2022